Aug. 30, 2022 – When members of the House and Senate return to Washington Sept. 6 following the Labor Day holiday, they face competing priorities and tight timeframes to take action on the federal budget and user fees, which expire on Sept. 30. Failure to pass the fiscal year 2023 (FY 2023) budget and reauthorize […]
Read more
Oct. 5, 2020 – Because Congress has not yet passed a budget, the federal government began fiscal year (FY) 2021 on Oct. 1 operating under a Continuing Resolution (CR). The CR sets a new deadline of Dec. 11 for passage of the full budget, but a further extension until February or March is very possible. […]
Read more
Feb. 17, 2020 — The Food and Drug Administration (FDA) began 2020 with continued momentum on drug approvals, a significant budget increase and a newly-confirmed Commissioner — Dr. Stephen Hahn – who has not yet presented his priorities for ongoing operations and new initiatives. But President Trump’s fiscal 2021 budget—released Feb. 10 – raises some […]
Read more July 29, 2019 — Last week’s agreement on parameters for the 2020 fiscal year federal budget is good news for the Food and Drug Administration (FDA). The greatest advantage of the deal for the White House, the Democratic leadership of the House, and the Republican leadership in the Senate, of course, is that it would […]
Read more